drugIndia
Cart
Nexovas TM 25 Tablet ER

Nexovas TM 25 Tablet ER

Cilnidipine (10mg) + Metoprolol Succinate (23.75mg) + Telmisartan (40mg)

Macleods Pharmaceuticals Pvt Ltd
Hypertension
113.44141.8020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 4%
Best Alternative100% Match

Metosartan LN 25 Tablet ER

Sun Pharmaceutical Industries Ltd

Cilnidipine 10mg
Metosartan LN 25 Tablet ER

Pack Size

1 units

Price

108.7520% off
Metosartan LN 25 Tablet ER is 100% same as Nexovas TM 25 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹5

that's 4% off!

composition
  1. Cilnidipine 10mg
  2. Metoprolol Succinate 23.75mg
  3. Telmisartan 40mg
Buy Now
113.4420% OFF
141.80

About This Medicine

Product description & overview

Nexovas TM 25 Tablet ER

Nexovas TM 25 Tablet ER is a once-daily extended-release formulation of Cilnidipine, Metoprolol Succinate, and Telmisartan, specifically designed for the management of hypertension (high blood pressure). This combination effectively targets multiple pathways in the body to reduce blood pressure.

* Cilnidipine works by relaxing blood vessels to lower blood pressure.
* Metoprolol Succinate inhibits the effects of adrenaline, thereby slowing down heart rate and decreasing its force of contraction for effective blood flow regulation.
* Telmisartan blocks the action of angiotensin II, a hormone that promotes vasoconstriction (narrowing of blood vessels), further reducing blood pressure.

Nexovas TM 25 Tablet ER is suitable for patients with hypertension who require a comprehensive approach to treatment and benefit from once-daily dosing with extended release for optimal efficacy. It's important to consult your healthcare professional before taking any medication.

Please note: This description is intended for informational purposes only and does not constitute medical advice. Always follow the directions of your doctor or pharmacist.

Active composition

Cilnidipine 10 mg

+2 more active ingredients

About Cilnidipine

Cilnidipine is a calcium channel blocker used to treat hypertension (high blood pressure). It works by relaxing blood vessels, thereby reducing the workload on the heart and improving blood flow. Cilnidipine is clinically significant in managing blood pressure and reducing the risk of cardiovascular events. In summary, cilnidipine is essential for controlling hypertension and enhancing heart health.

How It Works

Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.

Medicine Strength
10 mg

All Active Ingredients

Cilnidipine10 mg
Metoprolol Succinate23.75 mg
Telmisartan40 mg

Metoprolol Succinate

Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.

Telmisartan

Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Nexovas TM 25 Tablet ER.

High Risk

Pregnancy

Nexovas TM 25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Medical Advice

Driving

Nexovas TM 25 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Exercise Caution

Liver

Nexovas TM 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Nexovas TM 25 Tablet ER may be needed. Please consult your doctor. Use of Nexovas TM 25 Tablet ER is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Information regarding the use of Nexovas TM 25 Tablet ER during breastfeeding is not available. Please consult your doctor.

Consult Doctor

Kidney

There is limited information available on the use of Nexovas TM 25 Tablet ER in patients with kidney disease. Please consult your doctor.

Regular Checkup

Customer Reviews

0 reviews for Nexovas TM 25 Tablet ER

Products matching your search